Literature DB >> 17161468

Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits.

Nina M van Sorge1, Nobuhiro Yuki, Marc D Jansen, Yukihiro Nishimoto, Keiichiro Susuki, John H J Wokke, Jan G J van de Winkel, Leonard H van den Berg, W-Ludo van der Pol.   

Abstract

Acute motor axonal neuropathy (AMAN) in humans is associated with the presence of GM1-specific antibodies. Immunization of rabbits with GM1-containing ganglioside mixtures, purified GM1, or Campylobacter jejuni lipo-oligosaccharide exhibiting a GM1-like structure elicits GM1-specific antibodies, but axonal polyneuropathy only occurs in a subset of animals. This study aimed to dissect the molecular basis for the variable induction of AMAN in rabbits. Therefore, we analyzed the pro-inflammatory characteristics of GM1-specific antibodies in plasma samples from ganglioside-immunized rabbits with and without neurological deficits. GM1-specific plasma samples from all rabbits with AMAN were capable of activating both complement and leukocytes, in contrast to none of the plasma samples from rabbits without paralysis. Furthermore, GM1-specific IgG-mediated activation of leukocytes was detected before the onset of clinical signs. These data suggest that AMAN only occurs in rabbits that develop GM1-specific antibodies with pro-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161468     DOI: 10.1016/j.jneuroim.2006.10.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.

Authors:  John W Rumsey; Case Lorance; Max Jackson; Trevor Sasserath; Christopher W McAleer; Christopher J Long; Arindom Goswami; Melissa A Russo; Shruti M Raja; Karissa L Gable; Doug Emmett; Lisa D Hobson-Webb; Manisha Chopra; James F Howard; Jeffrey T Guptill; Michael J Storek; Miguel Alonso-Alonso; Nazem Atassi; Sandip Panicker; Graham Parry; Timothy Hammond; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2022-04-05

2.  Complement activity is associated with disease severity in multifocal motor neuropathy.

Authors:  Lotte Vlam; Elisabeth A Cats; Oliver Harschnitz; Marc D Jansen; Sanne Piepers; Jan Herman Veldink; Hessel Franssen; Abraham C J Stork; Erik Heezius; Suzan H M Rooijakkers; Bjorn L Herpers; Jos A van Strijp; Leonard H van den Berg; W Ludo van der Pol
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-06-25

3.  Multifocal motor neuropathy presenting as a post-infectious complication of dengue: a CASE report.

Authors:  Rakitha Higgoda; Dilshan Perera; Kanapathipillai Thirumavalavan
Journal:  BMC Infect Dis       Date:  2018-08-22       Impact factor: 3.090

Review 4.  Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment.

Authors:  Victoria H Lawson; W David Arnold
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-05       Impact factor: 2.570

Review 5.  MMN: from immunological cross-talk to conduction block.

Authors:  Oliver Harschnitz; Bas A Jongbloed; Hessel Franssen; Dirk C G Straver; W Ludo van der Pol; Leonard H van den Berg
Journal:  J Clin Immunol       Date:  2014-04-13       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.